Umoja Biopharma
@umojabiopharma
Next Generation Immunotherapies
ID: 1286058971774750720
22-07-2020 22:02:29
401 Tweet
336 Takipçi
180 Takip Edilen
Umoja will present at #SXSW! Our CEO, Andrew Scharenberg, MD, will join a dynamic panel with leading experts to discuss the revolutionary potential of viruses in medicine. Don't miss out, find more details here: brnw.ch/21wH0pD #MedicinesGoViral
Our CEO Andrew Scharenberg is participating in a virtual fireside chat at the Evercore ISI 2024 Emerging Biotech Conference on February 29 at 10:45 a.m. ET. Access the webcast here: brnw.ch/21wHdos
In a few days our CEO Andrew Scharenberg hits Austin, TX for #SXSW! He is joining Vincent Racaniello & Steffanie Strathdee, PhD 🗡️ 🦠Superbug Slayer🗡️ for a panel on March 12th to discuss the potential of viruses as medicines & our #VivoVec platform. Find more details here: schedule.sxsw.com/2024/events/PP… #MedicinesGoViral
Our CEO, Andrew Scharenberg, MD, has arrived at #SXSW for his presentation on how Umoja's using #LentiviralVectorsfor #CARTcelltherapies. Find additional information here: schedule.sxsw.com/2024/events/PP… #SXSW2024 #MedicinesGoViral
Our CEO, Andrew Scharenberg, will present a corporate overview at H.C. Wainwright & Co.’s 2nd Annual Cell Therapy Virtual Conference on March 26. Members of our leadership team will also be available for one-on-one meetings during the conference. Find more details here: umoja-biopharma.com/news/umoja-bio…
Our CEO, Andrew Scharenberg, MD, CAR T pioneer Carl June and Stephen Russell, MD, PhD will be in New York City for the Alliance for Cancer Gene Therapy Summit 2024 tomorrow to share insights on the progress and challenges of in vivo #CGT. Learn more here: bit.ly/3TzsZLS
Grateful to host Colorado School of Mines’ ambitious graduate students at The CLIMB earlier this month! We enjoyed sharing our #CGT vision for Umoja and The CLIMB with the next generation of #biotech leaders.
Our CEO, Andrew Scharenberg, MD, was recently featured on the Talking Biotech podcast! Listen to the episode to learn how Umoja is engineering #CARTcells #InVivo to create more effective #CellTherapies: share.transistor.fm/s/a2e93342
In our latest blog post, CEO Andrew Scharenberg reflects on his experience as a #SXSW2024 panelist and details his goal of advancing practice-changing #CellTherapies. Read more about the benefits of reimagining viruses as medicine: umoja-biopharma.com/blog/taking-th… #MedicinesGoViral
We are honored to announce the publication of the first successful #InVivo #CARTcell data in Blood Journal stemming from our pre-clinical investigations of our proprietary #VivoVec particles. Learn more about the validation of our #immunotherapy platform: umoja-biopharma.com/news/umoja-bio…